No Data
No Data
Earnings Preview: Eyenovia to Report Financial Results Post-market on November 12
$Eyenovia(EYEN.US)$ is scheduled to release its financial results post-market on November 12 ET. Earnings PreviewAnalysts estimate $Eyenovia(EYEN.US)$ to post revenue of USD112.00K for 2024Q3, up 9233
Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th
Eyenovia Announces Publication of Study Demonstrating Favorable Impact on the Ocular Surface of Medication Delivered With the Optejet
Evenovia Shares Are Trading Higher After the Company Announced It Will Present Results From Its Successful Phase 3 CPN-302 Study of Clobetasol Propionate Suspension 0.05% as a Treatment for Inflammation and Pain Following Ocular Surgery. The Results...
Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo
Express News | Eyenovia Files for Mixed Shelf Offering of up to $100 Mln- SEC Filing
No Data
No Data